# Honey and Nigella Sativa in COVID-19 Prophylaxis

> **NCT04767087** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Sohaib Ashraf** · enrollment: 1000 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Honey
- **DRUG:** Nigella sativa seed
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04767087
- **Lead sponsor:** Sohaib Ashraf
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-05
- **Primary completion:** 2022-02-15
- **Final completion:** 2022-04-15
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2021-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04767087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04767087, "Honey and Nigella Sativa in COVID-19 Prophylaxis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04767087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*